Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

High Grade Assays Verify the Emerging Manindi VTM Project

by admin February 18, 2026
February 18, 2026
High Grade Assays Verify the Emerging Manindi VTM Project

Metals Australia (MLS:AU) has announced High Grade Assays Verify the Emerging Manindi VTM Project

Download the PDF here.

This post appeared first on investingnews.com

previous post
Sigma Lithium Makes New Lithium Fines Sale, Unlocks US$96 Million Credit Facility
next post
Silverco Mining

Related Posts

Living Plants Offer New Path to Rare Earths...

November 18, 2025

Graphite Market Update: H1 2025 in Review

August 19, 2025

CMC Metals Ltd. Announces Share Consolidation and Name Change

March 22, 2025

Results of General Meeting, Admission of Retail Offer...

March 25, 2025

LaFleur Minerals Closes $1.66 Million Flow-Through Offering to...

November 1, 2025

Heliostar Drills 83.2m Grading 17.35 g/t Gold from...

November 24, 2025

Successful A$4.5m Two Tranche Placement

October 13, 2025

Placement Shares Issued & Drilling Approval Expected August

July 10, 2025

John Feneck: Silver’s Next Price Target, Plus 10...

January 29, 2026

US Antimony Wins US$245 Million Pentagon Deal to...

September 24, 2025

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved